Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
611918 | Ca2+ channel agonist 1 | 1402821-24-2 | 98% | |
Ca2+ channel agonist 1 is a N-type Ca2+ channel activity agonist, with EC50 of 14.23 | ||||
611912 | CX-4945 sodium salt | 1309357-15-0 | 98% | |
CX-4945 (Silmitasertib) sodium salt is a potent and selective ATP-competitive small m | ||||
611824 | CAL-130 Racemate | 474012-90-3 | 98% | |
CAL-130 racemate is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reporte | ||||
611823 | CAL-130 Hydrochloride | 1431697-78-7 | 98% | |
CAL-130 Hcl is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported tha | ||||
611822 | CAL-130 | 1431697-74-3 | 98% | |
CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that co | ||||
611816 | Compound 401 | 168425-64-7 | 98% | |
Compound 401 is a synthetic inhibitor of DNA-PK (IC50 = 0.28 M) that also targets mTO | ||||
611815 | CC-115 hydrochloride | 1300118-55-1 | 98% | |
CC-115 hydrochloride is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM). CC-115 shows go | ||||
611801 | 3 CAI | 28755-03-5 | 98% | |
3CAI is a potent allosteric and specific AKT inhibitor, which exerts efficacy in vitr | ||||
161009017 | Chrysophanic acid | 481-74-3 | 98% by HPLC | |
Chrysophanic acid preferentially blocked proliferation in SNU-C5 cells but not in oth | ||||
160926016 | CAY10505 | 1218777-13-9 | 98% by HPLC | |
CAY10505 is a phosphatidylinositol 3-kinase- inhibitor , was found to significantly i | ||||
160926015 | CH5132799 (PA-799) | 1007207-67-1 | 98% by HPLC | |
CH5132799, also known as PA-799, is a novel class I PI3K inhibitor, which exhibited a | ||||
16090101 | CCT245737 | 1489389-18-5 | 98% | |
CCT245737(CCT-245737, CAS 1489389-18-5) is the first orally active, clinical developm | ||||
16071407 | CWHM-12 | 1564286-55-0 | 98% by HPLC | |
vitro ligand-binding assays, with somewhat less potency against v5 than against the o | ||||
16071401 | CMK | 821794-90-5 | 98% by HPLC | |
CMK | ||||
16070917 | Copanlisib | 1032568-63-0 | ≧98.0% | |
Copanlisib, also known as BAY 80-6946, is a phosphoinositide 3-kinase (PI3K) inhibito | ||||
16070913 | CCT244747 | 1404095-34-6 | 98% by HPLC | |
CCT244747 is a novel potent, highly selective, orally active ATP-competitive CHK1 inh | ||||
16070704 | CP-673451 | 343787-29-1 | 98% by HPLC | |
CP-673451 is a selective inhibitor of PDGFR/ with IC50 of 10 nM/1 nM in cell-free ass | ||||
16062904 | CHIR-99021 | 252917-06-9 | 98% by HPLC | |
CHIR-99021, also known as CT99021, is a glycogen synthase kinase 3 (GSK3) inhibitor t | ||||
16062115 | CA-074 | 134448-10-5 | 98% by HPLC | |
CA-074 | ||||
16053104 | CF-102 | 163042-96-4 | 98% by HPLC | |
CF-102, also known as 2-Cl-IB-MECA, is an orally bioavailable, synthetic, highly sele | ||||
SSC65304 | CHIR-090 | 728865-23-4 | 98% by HPLC | |
CHIR-090 is a potent LpxC inhibitor, displays two-step time-dependent inhibition and | ||||
032509 | 4-cyclopropylphenylacetic acid | 40641-90-5 | 98% | |
Coming soon! | ||||
032506 | 2-Chloro-3-fluoro-4-(trifluoromethyl)pyridine | 628692-22-8 | 98% | |
Coming soon! | ||||
032402 | CEP-1347 | 156177-65-0 | 98% | |
Coming soon! | ||||
030201 | CPI-203 | 1446144-04-2 | 98% | |
CPI 203 is a novel potent, selective and cell permeable inhibitor of the bromodomain | ||||
022202 | CL-387785 | 194423-06-8 | 98% | |
CL-387785 is an irreversible inhibitor of EGFR with IC50 of 370+/-120 pM; is able to | ||||
021802 | CC-223 | 1228013-30-6 | 98% | |
CC-223 is a potent mTOR kinase inhibitor (IC50=16 nM), with >150-fold sensitivity | ||||
012601 | CJ-023423 | 415903-37-6 | 98% | |
CJ-023423 is a novel, potent and selective prostaglandin EP4 receptor antagonist with | ||||
012004 | CC-115 | 1228013-15-7 | 98% | |
CC-115 is a dual inhibitor of DNA-dependent protein kinase and mammalian target of ra | ||||
012002 | CB-5083 | 1542705-92-9 | 98% | |
CB-5083 is a novel first in class, potent orally bio-available p97 inhibitor that dis |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1